Searchable abstracts of presentations at key conferences in endocrinology

ea0083domnp1 | Diabetes, Obesity, Metabolism and Nutrition | EYES2022

Does phase angle analysis in overweight women be a surrogate marker of insulin resistance?

G Erta , G Gersone , P Tretjakovs

Background: Phase angle (PA) is defined as the angular displacement between the current and voltage waveforms due to capacitor interference, measured in degrees or radians. [1] The fat-free mass (FFM) is made up of water and electrolytes and is characterized by a low impedance, while the FM (fat mass) is water-free and, therefore, with a high impedance. The larger the FM, the higher the resistance, and this parameter affects the PA. Body mass index (BMI) is the most widely use...

ea0083eeo2 | Environmental Endocrinology | EYES2022

Influence of exposure to metaloestrogen – selenium on Leydig cell epigenetic status

M Duliban , P Pawlicki , M Kotula-Balak

Background: As a trace element selenium (Se) is essential for man and animals, in particular for the maintenance of spermatogenesis and male fertility. A growing number of evidence shows that Se is necessary for testosterone synthesis, and inappropriate concentration, Se can stimulate Leydig cell proliferation. However, Se can also act as a metalloestrogen, which can mimic estrogen and activate the estrogen receptors. In higher concentrations, Se might have an adverse effect o...

ea0088017 | Abstracts | BES2022

Prolactinomas: our experience in Liège

M Trebillod , L Vroonen , P Petrossians

Introduction: The true prevalence of clinically relevant pituitary adenomas has been reevaluated at 1/1064 of the population (1). Among them, prolactinomas represent the majority with a prevalence of 1/2000. They occur usually in females, aged 20–50 Y.O., and 80% are microadenomas. Nearly 5% of prolactinomas appear in a familial or genetic setting (MEN-1 or FIPA) (2). Cabergoline is proposed as the first line therapy and is usually efficient to normalize prolactin (PRL) l...

ea0064006 | Endocrine consequences of immune checkpoint inhibitors | BES2019

Endocrine consequences of immune checkpoint inhibitors

Chachati A-S , Potorac I , Petrossians P , Beckers A

Immune checkpoints inhibitors have fundamentally changed the management of oncologic patients. These treatments consist of monoclonal antibodies directed against CTLA-4 (cytotoxic T-lymphocyte antigen 4), PD-1 (programmed cell death protein-1) and PD-L1 (one of its ligands). By blocking these receptors or ligands, the antibodies reverse the immune tolerance induced by the cancerous cell on the T-lymphocyte and favour lymphocytic reactivation and anti-tumor activity. Immune tol...

ea0064024 | A case of meningioma after cyproterone acetate use | BES2019

A case of meningioma after cyproterone acetate use

Chasseur P , Bruneau M , Corvilain B

A 43-year-old roman, previously living in France was referred to the endocrinology department for Hashimoto’s hypothyroidism in 2017. Thyroid function was easily normalized by a treatment by thyroxine. She had also a medical history of severe alopecia since the age of 20. The diagnosis of androgenetic alopecia was made at that time by a French dermatologist and treatment by estradiol valerate 2 mg with cyproterone acetate (CPA) 50 mg was started. The dose of CPA was lower...

ea0064025 | A rare cause of central diabetes insipidus | BES2019

A rare cause of central diabetes insipidus

Chasseur P , Bahar N , Couturier B , Burniat A

Case: A 42-year old woman was referred to the endocrinology department for polydipsia and polyuria of sudden onset one month prior to presentation. She drank between 8 and 10 litres of water per day and complained of thirst, asthenia and lighter menstruation under her usual oral contraceptive pill. In addition to contraception she took 50 μg of L-thyroxine for Hashimoto thyroïditis. She had also a medical history of pink-red cutaneous lesions evolving for more than 1...

ea0049ep733 | Developmental endocrinology | ECE2017

Endocrinology training programs in member countries of the International Society of Endocrinology (ISE): a pilot survey evaluation comparing regions and cultures

Bastyr Maite P , Galofre Juan C

Background: Endocrinology is a relatively young subspecialty of internal medicine. No consensus on international standards for training has been established, and hence the variability between training programs and endocrinologist qualifications may be great.Methods: A standardized questionnaire was constructed to explore individual national standards for endocrinology training, evaluating the responding programs for physician entry criteria for each prog...

ea0047oc33 | Spotlight on Prostate Cancer | Theranostics2016

Molecular imaging with 64Cu-PSMA PET/CT in Theranostics of prostate cancer

Singh Aviral , Kulkarni Harshad , Baum Richard P.

Objectives: Copper-64 (64Cu, T1/2=12.7 h; Eβ+ max =0.65 MeV (17.9%); Eβ− max =0.57 MeV (39%)) is suitable for in-vivo PET imaging. Prostate specific membrane antigen (PSMA) is significantly over-expressed in undifferentiated prostate cancer tissue. We report the initial molecular imaging results with 64Cu-PSMA PET/CT in patients with prostate cancer.Methods: 64Cu labeled PSMA (mean administered ra...

ea0036P71 | (1) | BSPED2014

A novel de novo heterozygous mutation in FGFR1 is associated with Hartsfield syndrome

Prasad Rathi , Brewer Carole , Burren Christine P

Introduction: Hartsfield syndrome (#OMIM 615465) describes the rare co-occurrence of holoprosencephaly with ectrodactyly, associated with a spectrum of developmental defects including specific pituitary dysfunction.Case report: Our patient, a male infant, had several congenital abnormalities: bilateral cleft lip and palate, right sided microtia, bilateral ectrodactyly of the hands and feet and semilobar holoprosencephaly. Aged 5 weeks he was noted to be ...